MedPath

CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML

CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML

Discontinued
DIN Number

02163675

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02163675
AIG Number0127613001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DC10 CEFPROZIL
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationOral
AHFS Classification08:12.06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFPROZILActive
Strength: 125 MG / 5 ML
Monograph: CEFPROZIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.